Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @pkluetz
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @pkluetz
-
The
@FDAOncology annual report from 2019 is up on the web. A lot of work was accomplished to advance the development of cancer therapies, and there is a lot more to do...https://www.fda.gov/about-fda/oncology-center-excellence/oce-annual-report …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Kluetz proslijedio/la je Tweet
African Americans have the highest death rate & shortest survival of any racial/ethnic group in the US for most cancers. Join us Feb 6 for a
#BlackHistoryMonth
discussion, All Power to the Patient: Achieving Cancer Health Equity #OCEProjectCommunity https://fdaoce.formstack.com/forms/ocebhm2020 …pic.twitter.com/aK2NLYxdHQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
This will be a good opportunity to hear about a host of programs
@FDAOncology has put together over the past 3 years, and how they impact various stakeholdershttps://twitter.com/FDAMedia/status/1223236472578486273 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Kluetz proslijedio/la je Tweet
#FDAOncology wishes@BlumenthalG well as he leaves FDA for a new role. Dr. Blumenthal has had a large impact in cancer research & regulatory science and was a well-respected leader for oncology during his 14+ years of government service at FDA and NIH.pic.twitter.com/ulLyIaoJkZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thanks for having us join you Brian!https://twitter.com/KidneyCancerDoc/status/1221098583556083712 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Kluetz proslijedio/la je Tweet
You’re invited! Thurs, Feb 6,
#FDAOncology is hosting a Black History Month panel discussion open to the public: “All Power to the Patient – Achieving Cancer Health Equity” at the FDA Great Room noon-1 pm.#OCEProjectCommunity Register here https://fdaoce.formstack.com/forms/ocebhm2020 …pic.twitter.com/QNcEKq3blb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Kluetz proslijedio/la je Tweet
I am delighted to announce that Dr.
@AnandShahFDA has returned to the FDA from the Centers for Medicare & Medicaid Services@CMSgov as the Deputy Commissioner for Medical and Scientific Affairs.pic.twitter.com/cNQXbik4Yy
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Kluetz proslijedio/la je Tweet
Join keynote speaker
@NCIDirector and#FDAOncology's@realrickpazdur for our birthday recognition and public meeting on Feb. 5 at FDA or online to discuss the future of oncology drug development#OCEProject2025 https://go.usa.gov/xdxBB pic.twitter.com/hY3c4GkA59
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Kluetz proslijedio/la je Tweet
Today,
@AmericanCancer released their annual Cancer Statistics report. The study found overall cancer mortality dropped 2.2% from 2016-17—the largest one-year drop ever recorded—thanks largely to improvements in certain lung cancer & melanoma treatments.https://www.nytimes.com/2020/01/08/health/cancer-deaths-decline.html …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Kluetz proslijedio/la je Tweet
As this report demonstrates, the progress we are making in
#CancerResearch is marvelous.https://twitter.com/AmericanCancer/status/1214892936531456001 …
0:11Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Kluetz proslijedio/la je Tweet
Register now for the Feb. 13
#FDAOncology -@AACR Workshop to Examine Under-representation of African Americans in Multiple Myeloma Clinical Trials. Help us work to address a major disparity in cancer care!#MyelomaDiversity https://www.aacr.org/AdvocacyPolicy/GovernmentAffairs/Pages/multiple-myeloma-clinical-trials.aspx … http://j.mp/2ZUnL0UHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Kluetz proslijedio/la je Tweet
A mounting public health tragedy in urgent need of renewed focus.https://twitter.com/MichaelRStrain/status/1214171449088520192 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Kluetz proslijedio/la je Tweet
Happy New Year and Happy 3rd Birthday to us! Join us Feb. 5 for a public meeting (in person/online) to discuss future cancer drug development - FDA Oncology Center of Excellence Update: Envisioning Oncology and Product Development for 2025
#OCEProject2025 http://j.mp/2QN5cYl pic.twitter.com/IWUU6CSNZR
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Interested in cancer therapeutic development? Celebrate the 3rd year of
@FDAOncology on February 5th at the Silver Spring, MD FDA campus. Hear updates on multiple innovative#OCE projects! Register to attend in person or remotely-https://fdaoce.formstack.com/forms/oceprojectsupdate …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Immune toxicities... SO important ED docs ask cancer patients if they are on IO agents. Fantastic
#NCI article on immune side effects featuring my friend@EladSharonMD and an ED doc from my alma mater@UMEmergencyMed,@sbuidubbs FYI@amalmattu .https://www.cancer.gov/news-events/cancer-currents-blog/2019/cancer-immunotherapy-investigating-side-effects …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
For 2020, be collaborative, thoughtful and respectful as we work together on issues big and small. My son asked, "what difference can I make?" I tell him every human interaction can make a difference. Make them all count. Oh, and have fun and a sense of humor... you'll need it!
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Kluetz proslijedio/la je Tweet
Thanks to all for their work on these trials and reviews, and thanks most of all to the patients for participating. What will 2020 have in store---- much work still to be done.
@FDAOncology approvals to date https://www.fda.gov/drugs/resources-information-approved-drugs/hematologyoncology-cancer-approvals-safety-notifications … 2/2Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Wishing our
@FDAOncology ORISE fellow Jessica Roydhouse success and fulfillment as she begins her career advancing health outcomes research in Tasmania!pic.twitter.com/qJNiZp2rBL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Kluetz proslijedio/la je Tweet
All of us at the FDA wish you the happiest of holidays!pic.twitter.com/WM8FSJso1H
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paul Kluetz proslijedio/la je Tweet
I am honored to serve as the 24th Commissioner of Food and Drugs. I would like to thank
@SecAzar for swearing me in today and@POTUS for the opportunity to lead FDA. I would also like to thank my family for their support throughout this process.pic.twitter.com/w1MwrzhFrl
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.